scholarly journals Major Surgery Suppresses Maximal Production of Helper T-Cell Type 1 Cytokines Without Potentiating the Release of Helper T-Cell Type 2 Cytokines

1999 ◽  
Vol 134 (5) ◽  
pp. 540-544 ◽  
Author(s):  
R. Berguer
2003 ◽  
Vol 11 (2) ◽  
pp. 169-173 ◽  
Author(s):  
Yutaka Iida ◽  
Hisashi Iwata ◽  
Yoshio Mori ◽  
Hisato Takagi ◽  
Toyoo Nitta ◽  
...  

2003 ◽  
Vol 168 (2) ◽  
pp. 215-221 ◽  
Author(s):  
Stéphanie Sénéchal ◽  
Patricia de Nadai ◽  
Natacha Ralainirina ◽  
Arnaud Scherpereel ◽  
Han Vorng ◽  
...  

1999 ◽  
Vol 237 (5) ◽  
pp. 399-406 ◽  
Author(s):  
A. Heiligenhaus ◽  
Dirk Bauer ◽  
Mei Zheng ◽  
Stefanie Mrzyk ◽  
Klaus-Peter Steuhl
Keyword(s):  
T Cell ◽  

1988 ◽  
Vol 85 (20) ◽  
pp. 7724-7728 ◽  
Author(s):  
V. M. Sanders ◽  
R. Fernandez-Botran ◽  
R. L. Coffman ◽  
T. R. Mosmann ◽  
E. S. Vitetta
Keyword(s):  
T Cell ◽  
B Cell ◽  

1998 ◽  
Vol 9 (13) ◽  
pp. 1899-1907 ◽  
Author(s):  
Patricia S. Walker ◽  
Tanya Scharton-Kersten ◽  
Edgar D. Rowton ◽  
Ulrich Hengge ◽  
Anne Bouloc ◽  
...  

1999 ◽  
Vol 6 (1) ◽  
pp. 79-84 ◽  
Author(s):  
Bang-Ning Lee ◽  
Madeleine Duvic ◽  
Chih-Kwang Tang ◽  
Carlos Bueso-Ramos ◽  
Zeev Estrov ◽  
...  

ABSTRACT Mycosis fungoides (MF) and Sezary syndrome (SS) are the two main clinical entities of cutaneous T-cell lymphoma (CTCL). As the disease progresses from MF to SS, a switch from a type 1 (interleukin [IL]-2 and gamma interferon [IFN-γ]) to a type 2 (IL-4) cytokine production profile occurs. Although roles for type 1 and type 2 cytokines in the pathogenesis of CTCL have been proposed, the cellular origins of these cytokines are unclear. Using flow cytometry to identify individual T-cell subsets, we studied cytokine synthesis by the T cells of 13 patients with SS and 12 with MF and 9 hematologically healthy donors. Upon activation with phorbol 12-myristate 13-acetate (PMA), the numbers of T cells synthesizing IL-2 were similar for all study groups. Whereas the predominant T-cell producing IL-2 in healthy donors and in those with MF was CD7+, in patients with SS, it was CD7−. Although the number of IL-4+CD4+ T cells was low for all study groups, there was a significantly higher number of IL-4+ CD8+ T cells in patients with MF than in those with SS or healthy donors. There was a decline in the number of IFN-γ-producing T cells in CTCL donors compared to that in healthy donors. More importantly, there was a significant decrease in the number of IFN-γ-producing T cells with disease progression from MF to SS. The inability of these T cells to synthesize IFN-γ may have prognostic value in CTCL, since it may be responsible for the progression of the disease from MF to SS.


2018 ◽  
Vol 188 (2) ◽  
pp. 417-431 ◽  
Author(s):  
Pablo A. Iturra ◽  
Diego A. Rojas ◽  
Francisco J. Pérez ◽  
Andrea Méndez ◽  
Carolina A. Ponce ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document